Working... Menu

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01730534
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : October 2, 2018
Bristol-Myers Squibb
The TIMI Study Group
Hadassah Medical Organization
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 11, 2018
  Actual Study Completion Date : September 11, 2018
Publications automatically indexed to this study by Identifier (NCT Number):